Valuation: RAMM Pharma Corp.

Market Cap 11.94L 8L 7L 7L 6L 8Cr 12.12L 81.07L 31.52L 3.93Cr 31.55L 30.87L 14Cr P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 5L 3L 3L 3L 2L 3.15Cr 5L 31.94L 12.42L 1.55Cr 12.43L 12.16L 5.34Cr EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
1 week-33.33%
1 month-33.33%
3 months-50.00%
6 months-83.33%
Current year-83.33%
1 week 0
Extreme 0.005
0.01
1 month 0
Extreme 0.005
0.01
Current year 0
Extreme 0.005
0.05
1 year 0
Extreme 0.005
0.25
3 years 0
Extreme 0
0.25
5 years 0
Extreme 0
0.85
10 years 0
Extreme 0
1.19
Manager TitleAgeSince
Chief Executive Officer - 01/10/2019
Director of Finance/CFO - 09/12/2022
Director TitleAgeSince
Director/Board Member - 01/10/2019
Director/Board Member 82 01/10/2019
Director/Board Member 66 01/10/2019
Date Insider Type Main position Quantity % Market Cap.
02/25/02Sell

Chief Executive Officer

46,67,000 3.9091%
21/25/21Buy

Chief Executive Officer

1,00,000 0.0838%
21/25/21Buy

Chief Executive Officer

2,00,000 0.1675%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-33.33%0.00%-85.71% 8L
+1.86%+0.48%+55.50%+163.08% 1,08200Cr
+3.57%+3.29%+68.60%+61.03% 63TCr
+3.99%+3.05%+37.93%+93.37% 46TCr
+3.86%+1.64%+31.35%+24.29% 34TCr
-0.56%+0.96%+39.86%+36.64% 30TCr
-0.08%+1.30%+30.37%+44.02% 29TCr
-1.54%+2.81%-27.56%-39.45% 22TCr
+3.55%+4.41%+25.45%+66.28% 20TCr
+4.21%+2.65%+17.47%+71.11% 16TCr
Average +1.89%+4.12%+27.90%+43.47% 36.92TCr
Weighted average by Cap. +2.25%+5.53%+41.78%+83.01%

Financials

2024 2025
Net sales 43.42L 30.57L 26.72L 24.56L 22.89L 29Cr 44.08L 2.95Cr 1.15Cr 14Cr 1.15Cr 1.12Cr 49Cr 33.61L 23.66L 20.68L 19.01L 17.72L 23Cr 34.12L 2.28Cr 88.71L 11Cr 88.81L 86.9L 38Cr
Net income -1.65Cr -1.16Cr -1.02Cr -93.34L -87L -110.62Cr -1.68Cr -11Cr -4.36Cr -54Cr -4.36Cr -4.27Cr -187.38Cr -89.1L -62.73L -54.84L -50.4L -46.98L -60Cr -90.45L -6.05Cr -2.35Cr -29Cr -2.35Cr -2.3Cr -101.17Cr
Net Debt -6L -4L -4L -4L -3L -4.19Cr -6L -42.49L -16.52L -2.06Cr -16.54L -16.18L -7.11Cr -7L -5L -4L -4L -4L -4.85Cr -7L -49.13L -19.1L -2.38Cr -19.12L -18.71L -8.22Cr
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-
Date Price Change Volume
03/26/03 CA$0.0100 0.00% 1,000
30/26/30 CA$0.0100 0.00% 65,000
  1. Stock Market
  2. Stocks
  3. RAMM Stock